| mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
1e-07 |
| mRNA |
Imatinib |
GDSC1000 |
pan-cancer |
AAC |
0.23 |
5e-06 |
| mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
6e-06 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-06 |
| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
TL-1-85 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0001 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
NG-25 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0002 |
| mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0003 |
| mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |